Skip to main content
VEEVVeeva Systems Inc.Buy Wait6.5·$262.39+0.00%

Veeva Systems (VEEV) Q2 2026 earnings — TrendMatrix coverage

BEAT+5.8% vs estimateEPS $2.35 vs $2.22 estVerdict HoldBuy (Wait)

Reported

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure

Event detail · Q2 2026

Key numbers

Reported EPS
$2.35
Estimate
$2.22
Surprise
+5.8%
Revenue (period 2026-07-31)
$928.0M
Score at report (before → after)
5.96.3/10

Revenue source: xbrl.

Report record · Q2 2026

How the report landed

Veeva Systems (VEEV) beat the $2.22 estimate with diluted EPS of $2.35 — a clear 5.8% upside surprise. TrendMatrix's engine moved from Hold (5.9/10) to Buy (Wait) at 6.3/10 after the report.

Current read · as of 2026-09-15

Where TrendMatrix's rating stands now

TrendMatrix currently rates VEEV Buy (Wait) at 6.5/10.

4 of the last 4 quarters beat the estimate; this quarter's +5.8% surprise compares with a +5.4% four-quarter average. Next scheduled report: 2026-11-25.

What supports the rating

  • V7 flight-to-quality bonus: +0.5 (Q=8.4 in RISK_OFF)
  • Sector modifier (Healthcare): +0.5

What argues against it

  • Concentration risk — Geographic: North America
  • Analyst target reached - limited upside remaining
  • Expensive valuation

This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.

Current engine read

The levels TrendMatrix's engine tracks

Current price
$262.39
Entry target
$244.06
Price target
$267.57
Stop
$220.79
Upside to target
+2.0%
Reward-to-risk
0.1:1

The stock trades at 43.1× trailing but 25.6× forward earnings — consensus estimates already build in a substantial earnings recovery.

Model outputs from TrendMatrix’s engine as of 2026-09-15 — shown for context, not personalized investment advice.

Healthcare context

VEEV at TrendMatrix's latest read

Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.

Industry
Health Information Services
Market cap
$42.48B
P/E (fwd)
25.6
P/E (ttm)
43.1
52-week range
$148.05$310.50
Off 52-week high
15.5%
RSI (14)
59
Volume vs avg
0.77×
Score today
6.5/10

Earnings figures are sourced from TrendMatrix’s pipeline (EPS: existing earnings extraction; revenue: SEC XBRL company facts where available, yfinance-provisional otherwise). Not a buy/sell rating, a price target, or investment advice — see the current verdict on the stock’s main page for TrendMatrix’s live read.

Home Stocks VEEV Earnings Q2 2026 earnings